Home

Insights

PE

Lincoln Pharmaceuticals Ltd P/E Ratio

Lincoln Pharmaceuticals Ltd P/E Ratio

download
stocks purchased

₹ 0.3 Cr

Volume transacted

stocks purchased

4.9 K

stocks traded

Last Updated time: 13 Jul 14:33 PM

Image

Lincoln Pharmaceuticals Ltd

NSE: LINCOLN

PE

13.9

Last updated : 13 Jul 14:33 PM

Key Highlights

    The P/E Ratio of Lincoln Pharmaceuticals Ltd is 13.9 as of 13 Jul 14:33 PM .a1#The P/E Ratio of Lincoln Pharmaceuticals Ltd changed from 8.7 on March 2019 to 9.3 on March 2023 . This represents a CAGR of 1.34% over 5 years. a1#The Latest Trading Price of Lincoln Pharmaceuticals Ltd is ₹ 647.65 as of 12 Jul 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.5 to 27.2 in 5 years. This represents a CAGR of -0.93%a1# The PE Ratio of Automobile industry is 17.2. The PE Ratio of Finance industry is 24.7. The PE Ratio of IT - Software industry is 29.2. The PE Ratio of Pharmaceuticals industry is 37.5. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 12.1. In 2024a1#The Market Cap of Lincoln Pharmaceuticals Ltd changed from ₹ 425.1 crore on March 2019 to ₹ 678.41 crore on March 2023 . This represents a CAGR of 9.80% over 5 years. a1#The Revenue of Lincoln Pharmaceuticals Ltd changed from ₹ 129.97 crore to ₹ 149.51 crore over 8 quarters. This represents a CAGR of 7.25% a1#The EBITDA of Lincoln Pharmaceuticals Ltd changed from ₹ 23.41 crore to ₹ 25.4 crore over 8 quarters. This represents a CAGR of 4.16% a1#The Net Pr of Lincoln Pharmaceuticals Ltd changed from ₹ 15.01 crore to ₹ 18.6 crore over 8 quarters. This represents a CAGR of 11.32% a1#The Dividend Payout of Lincoln Pharmaceuticals Ltd changed from 6.43 % on March 2019 to 4.12 % on March 2023 . This represents a CAGR of -8.52% over 5 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Lincoln Pharmaceuticals Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Lincoln Pharmaceuticals Ltd

Period
Mar '198.7
Mar '205.2
Mar '217.2
Mar '229
Mar '239.3

Company Fundamentals for Lincoln Pharmaceuticals Ltd

Market Cap

1,297 Cr

EPS

46.6

P/E Ratio (TTM) *

13.9

P/B Ratio (TTM) *

2.2

Day’s High

665.6

Day’s Low

644.65

DTE *

0.0

ROE *

15.7

52 Week High

754.25

52 Week Low

392.0

ROCE *

20.7

* All values are consolidated

Last Updated time: 13 Jul 14:33 PM

* All values are consolidated

Last Updated time: 13 Jul 14:33 PM

Image

Lincoln Pharmaceuticals Ltd

NSE: LINCOLN

PRICE

647.65

-12.40 (-1.88%)

stock direction

Last updated : 12 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Lincoln Pharmaceuticals Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

Asset Value vs Market Value of Lincoln Pharmaceuticals Ltd

Market Value

1,297

Asset Value

277

3.7 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Lincoln Pharmaceuticals Ltd131,297
Sun Pharmaceuticals Industries Ltd37378,675
Cipla Ltd28122,093
Divis Laboratories Ltd75120,480
Zydus Lifesciences Ltd30118,217
Dr Reddys Laboratories Ltd20112,137

Key Valuation Metric of Lincoln Pharmaceuticals Ltd

Earnings

93 Cr

13.9 X

PE Ratio

Market Cap

₹1297Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

93 Cr

13.9 X

PE Ratio

Market Cap

₹1297Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Lincoln Pharmaceuticals Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Lincoln Pharmaceuticals Ltd

Period
Mar '19425
Mar '20268
Mar '21449
Mar '22623
Mar '23678

* All values are a in crore

×

Historical Revenue of Lincoln Pharmaceuticals Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Lincoln Pharmaceuticals Ltd

Period
Jun '22130
Sep '22146
Dec '22140
Mar '23116
Jun '23143
Sep '23165
Dec '23157
Mar '24150

* All values are a in crore

×

Historical EBITDA of Lincoln Pharmaceuticals Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Lincoln Pharmaceuticals Ltd

Period
Jun '2223
Sep '2235
Dec '2233
Mar '2321
Jun '2328
Sep '2340
Dec '2341
Mar '2425

* All values are a in crore

×

Historical Net Profit of Lincoln Pharmaceuticals Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Lincoln Pharmaceuticals Ltd

Period
Jun '2215
Sep '2224
Dec '2222
Mar '2313
Jun '2319
Sep '2328
Dec '2328
Mar '2419

* All values are a in crore

×

Historical Dividend Payout of Lincoln Pharmaceuticals Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Lincoln Pharmaceuticals Ltd

Period
Mar '196
Mar '206
Mar '215
Mar '224
Mar '234

* All values are a in %

About Lincoln Pharmaceuticals Ltd

About Lincoln Pharmaceuticals Ltd

    Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in Jan 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95. All the assets and business of the erstwhile partnership were transferred to the Company. The Company is engaged in the business of manufacturing and trading of pharmaceutical products. The company was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments. It is also getting its products manufactured on loan licence basis from other manufacturers to meet the demand of small volume parenterals. The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district), Gujarat, to manufacture small volume parenterals like dry powder injectables, liquid vial, liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake in-house testing of its products for better quality control and R&D. It came out with a public issue in Feb.'96 to part-finance its project. The Company launched Next Generation Progesterone Therapy 'ProlinSpray' during the year 2018. During the year 2021-22, Lincoln Parenteral Limited (Transferor Company), an erstwhile subsidiary, merged with Lincoln Pharmaceuticals Limited (the Transferee Company) through the Scheme of Amalgamation and consequent to this, the Transferor Company ceases to be the subsidiary of the Company. The Company acquired a plant in Mehsana, Gujarat to launch Cephalosporin products in 2022.

Lincoln Pharmaceuticals Ltd News Hub

News

Board of Lincoln Pharmaceuticals recommends Final Dividend

Lincoln Pharmaceuticals announced that the Board of Directors of the Company at its meetin...

Read more

16 May 202412:16

News

Lincoln Pharmaceuticals to announce Quarterly Result

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16...

Read more

09 May 202410:42

News

Lincoln Pharmaceuticals to convene board meeting

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 8 ...

Read more

25 Jan 202417:54

News

Lincoln Pharmaceuticals announces board meeting date

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2 ...

Read more

25 Oct 202317:20

News

Lincoln Pharmaceuticals to conduct AGM

Lincoln Pharmaceuticals announced that the 29th Annual General Meeting (AGM) of the compan...

Read more

29 Aug 202316:30

News

Lincoln Pharmaceuticals to announce Quarterly Result

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10...

Read more

07 Aug 202310:25

Product Composition by Percentage (Revenue)

FAQs for PE of Lincoln Pharmaceuticals Ltd

What is Lincoln Pharmaceuticals Ltd current share price?

The current market price of Lincoln Pharmaceuticals Ltd as of July 13, 2024 is ₹647.65.

What is Lincoln Pharmaceuticals Ltd's market cap?

Lincoln Pharmaceuticals Ltd's market capitalisation stood at ₹1,297 Cr as of July 13, 2024

What are Lincoln Pharmaceuticals Ltd's total net assets?

According to Lincoln Pharmaceuticals Ltd's most recent financial filings, the company's net assets total ₹276.6 Cr.

Is Lincoln Pharmaceuticals Ltd making a profit or loss?

Lincoln Pharmaceuticals Ltd's net Profit as of July 13, 2024 is close to ₹93 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199